Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Allinaire Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Allinaire Therapeutics

Allinaire Therapeutics

Allinaire Therapeutics: Innovating novel therapeutics for COPD and other pulmonary diseases.

HQ
Cleveland, OH, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Allinaire Therapeutics, founded in 2016 by BioMotiv with licensed technology from Indiana University, focuses on developing novel therapeutics for cardiopulmonary diseases, including Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Arterial Hypertension (PAH). The core mission of Allinaire is to innovate and provide disease-modifying treatments that significantly improve patient outcomes. Their primary product in development is a humanized anti-endothelial monocyte activating polypeptide II (EMAP II) monoclonal antibody.

Notable affiliations include BioMotiv, now managed by Advent Life Sciences, which provides strategic support and investment. Key achievements include the progression of their EMAP II monoclonal antibodies as a potential treatment for PAH. Allinaire's impact lies in its potential to transform the treatment landscape for severe pulmonary diseases, offering hope for improved quality of life for patients suffering from these conditions.

Allinaire Therapeutics - Similar Companies

Allorion Therapeutics logo

Allorion Therapeutics

alloriontx.com

Allyx Therapeutics logo

Allyx Therapeutics

allyxthera.com

Alveolus Bio logo

Alveolus Bio

alveolusbio.com

Airway Therapeutics logo

Airway Therapeutics

Allay Therapeutics logo

Allay Therapeutics

allaytx.com

Allterum Therapeutics logo

Allterum Therapeutics

allterum.com

Amplicore logo

Amplicore

Arialys Therapeutics logo

Arialys Therapeutics

arialysrx.com

Lung Biotechnology logo

Lung Biotechnology

unither.com

Allander Biotechnologies logo

Allander Biotechnologies

Aqualung Therapeutics logo

Aqualung Therapeutics

Enalare Therapeutics logo

Enalare Therapeutics

enalare.com

Aer Therapeutics logo

Aer Therapeutics

Therini Bio logo

Therini Bio

therinibio.com

Indalo Therapeutics logo

Indalo Therapeutics

Allinaire Therapeutics - Quick Facts

Who are Allinaire Therapeutics' competitors?

Companies similar to Allinaire Therapeutics include Allorion Therapeutics, Allyx Therapeutics, Alveolus Bio and Airway Therapeutics.

When was Allinaire Therapeutics founded?

Allinaire Therapeutics was founded in 2016.

Where is Allinaire Therapeutics' headquarters located?

Allinaire Therapeutics' headquarters is located in Cleveland, OH, US.

When was Allinaire Therapeutics' last funding round?

Allinaire Therapeutics' most recent funding round was for $1.6M (USD) in January 2017.

How much has Allinaire Therapeutics raised to-date?

As of Jan 27, 2017, Allinaire Therapeutics has raised a total of $1.6M (USD).

How many employees does Allinaire Therapeutics have?

Allinaire Therapeutics has 9 employees as of Feb 5, 2024.

Allinaire Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified